Societal Impacts of Health Disparities, Cultural Norms, and Technological Shifts

Frame the question

This guide examines how societal structures shape health outcomes, cultural behaviors, and technological integration. It explores the interplay between global health inequities, racial disparities, evolutionary psychology, and AI's role in research. The central question: How do systemic inequities and cultural norms influence health trajectories and societal development, and what implications do emerging technologies hold for these dynamics?

What the evidence shows

The Global Burden of Disease Study 2021 reveals that while global DALYs increased from 2.63 billion (95% UI 2.44-2.85) in 2010 to 2.88 billion (2.64-3.15) in 2021, age-standardised rates for HIV/AIDS and diarrhoeal diseases decreased by 47.8% and 47.0% respectively [1]. These trends contrast with the 7.2% rise in global age-standardised all-cause DALY rates during 2020-2021, attributed to the COVID-19 pandemic. Racial disparities in health persist: adjusting for education and income reduces but does not eliminate black-white health gaps, with perceived discrimination and stress remaining incremental factors [2]. Evolutionary psychology suggests males prioritize reproductive capacity indicators, while females value resource acquisition cues, a pattern consistent across 37 cultures [3]. Meanwhile, generative AI like ChatGPT offers productivity gains but raises ethical concerns about bias, misinformation, and the need for regulatory frameworks [4].

Follow the source trail

The Global Burden of Disease Study (GBD 2021) establishes a baseline for understanding health disparities through quantitative metrics like DALYs and HALE [1]. Racial health differences are contextualized within socioeconomic frameworks, showing how structural inequities compound biological vulnerabilities [2]. Evolutionary psychology provides a cross-cultural lens to analyze human behavior, revealing persistent sex-based preferences despite modernization [3]. Generative AI introduces a new variable: its potential to both democratize knowledge and exacerbate existing inequities through algorithmic bias [4]. These sources collectively demonstrate how societal structures—economic, cultural, and technological—interact to shape human health and behavior.

Use these sources well

Students should integrate these sources to build a layered argument: use GBD 2021 data to quantify health inequities [1], reference racial disparities to contextualize social determinants [2], apply evolutionary psychology to analyze cultural norms [3], and examine AI's role as both a disruptor and a potential solution [4]. For example, juxtapose the 47.8% decline in HIV/AIDS DALY rates [1] with the persistent racial health gaps [2] to argue that structural inequities outpace medical progress. When discussing AI, contrast its productivity benefits [4] with the ethical risks of algorithmic bias, using the GBD study's emphasis on evidence-based interventions as a framework for responsible innovation.

What to search next

How might AI-driven health analytics address or exacerbate existing racial disparities in disease burden? What cultural factors could explain variations in mate preference patterns beyond evolutionary psychology? How should academic institutions balance the benefits of generative AI with its risks to research integrity? What role should global health metrics play in shaping AI ethics frameworks? These questions highlight the need for interdisciplinary research that bridges public health, sociology, and technology studies.

Verbatim source abstracts

[1] Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 — The Lancet, 2024-04-17, doi:10.1016/s0140-6736(24)00757-8

BACKGROUND: Detailed, comprehensive, and timely reporting on population health by underlying causes of disability and premature death is crucial to understanding and responding to complex patterns of disease and injury burden over time and across age groups, sexes, and locations. The availability of disease burden estimates can promote evidence-based interventions that enable public health researchers, policy makers, and other professionals to implement strategies that can mitigate diseases. It can also facilitate more rigorous monitoring of progress towards national and international health targets, such as the Sustainable Development Goals. For three decades, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) has filled that need. A global network of collaborators contributed to the production of GBD 2021 by providing, reviewing, and analysing all available data. GBD estimates are updated routinely with additional data and refined analytical methods. GBD 2021 presents, for the first time, estimates of health loss due to the COVID-19 pandemic. METHODS: The GBD 2021 disease and injury burden analysis estimated years lived with disability (YLDs), years of life lost (YLLs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries using 100 983 data sources. Data were extracted from vital registration systems, verbal autopsies, censuses, household surveys, disease-specific registries, health service contact data, and other sources. YLDs were calculated by multiplying cause-age-sex-location-year-specific prevalence of sequelae by their respective disability weights, for each disease and injury. YLLs were calculated by multiplying cause-age-sex-location-year-specific deaths by the standard life expectancy at the age that death occurred. DALYs were calculated by summing YLDs and YLLs. HALE estimates were produced using YLDs per capita and age-specific mortality rates by location, age, sex, year, and cause. 95% uncertainty intervals (UIs) were generated for all final estimates as the 2·5th and 97·5th percentiles values of 500 draws. Uncertainty was propagated at each step of the estimation process. Counts and age-standardised rates were calculated globally, for seven super-regions, 21 regions, 204 countries and territories (including 21 countries with subnational locations), and 811 subnational locations, from 1990 to 2021. Here we report data for 2010 to 2021 to highlight trends in disease burden over the past decade and through the first 2 years of the COVID-19 pandemic. FINDINGS: Global DALYs increased from 2·63 billion (95% UI 2·44-2·85) in 2010 to 2·88 billion (2·64-3·15) in 2021 for all causes combined. Much of this increase in the number of DALYs was due to population growth and ageing, as indicated by a decrease in global age-standardised all-cause DALY rates of 14·2% (95% UI 10·7-17·3) between 2010 and 2019. Notably, however, this decrease in rates reversed during the first 2 years of the COVID-19 pandemic, with increases in global age-standardised all-cause DALY rates since 2019 of 4·1% (1·8-6·3) in 2020 and 7·2% (4·7-10·0) in 2021. In 2021, COVID-19 was the leading cause of DALYs globally (212·0 million [198·0-234·5] DALYs), followed by ischaemic heart disease (188·3 million [176·7-198·3]), neonatal disorders (186·3 million [162·3-214·9]), and stroke (160·4 million [148·0-171·7]). However, notable health gains were seen among other leading communicable, maternal, neonatal, and nutritional (CMNN) diseases. Globally between 2010 and 2021, the age-standardised DALY rates for HIV/AIDS decreased by 47·8% (43·3-51·7) and for diarrhoeal diseases decreased by 47·0% (39·9-52·9). Non-communicable diseases contributed 1·73 billion (95% UI 1·54-1·94) DALYs in 2021, with a decrease in age-standardised DALY rates since 2010 of 6·4% (95% UI 3·5-9·5). Between 2010 and 2021, among the 25 leading Level 3 causes, age-standardised DALY rates increased most substantially for anxiety disorders (16·7% [14·0-19·8]), depressive disorders (16·4% [11·9-21·3]), and diabetes (14·0% [10·0-17·4]). Age-standardised DALY rates due to injuries decreased globally by 24·0% (20·7-27·2) between 2010 and 2021, although improvements were not uniform across locations, ages, and sexes. Globally, HALE at birth improved slightly, from 61·3 years (58·6-63·6) in 2010 to 62·2 years (59·4-64·7) in 2021. However, despite this overall increase, HALE decreased by 2·2% (1·6-2·9) between 2019 and 2021. INTERPRETATION: Putting the COVID-19 pandemic in the context of a mutually exclusive and collectively exhaustive list of causes of health loss is crucial to understanding its impact and ensuring that health funding and policy address needs at both local and global levels through cost-effective and evidence-based interventions. A global epidemiological transition remains underway. Our findings suggest that prioritising non-communicable disease prevention and treatment policies, as well as strengthening health systems, continues to be crucially important. The progress on reducing the burden of CMNN diseases must not stall; although global trends are improving, the burden of CMNN diseases remains unacceptably high. Evidence-based interventions will help save the lives of young children and mothers and improve the overall health and economic conditions of societies across the world. Governments and multilateral organisations should prioritise pandemic preparedness planning alongside efforts to reduce the burden of diseases and injuries that will strain resources in the coming decades. FUNDING: Bill & Melinda Gates Foundation. [1]

[2] Racial Differences in Physical and Mental Health — Journal of Health Psychology, 1997-07-01, doi:10.1177/135910539700200305

This article examines the extent to which racial differences in socio-economic status (SES), social class and acute and chronic indicators of perceived discrimination, as well as general measures of stress can account for black-white differences in self-reported measures of physical and mental health. The observed racial differences in health were markedly reduced when adjusted for education and especially income. However, both perceived discrimination and more traditional measures of stress are related to health and play an incremental role in accounting for differences between the races in health status. These findings underscore the need for research efforts to identify the complex ways in which economic and non-economic forms of discrimination relate to each other and combine with socio-economic position and other risk factors and resources to affect health. [2]

[3] Sex differences in human mate preferences: Evolutionary hypotheses tested in 37 cultures — Behavioral and Brain Sciences, 1989-03-01, doi:10.1017/s0140525x00023992

Abstract Contemporary mate preferences can provide important clues to human reproductive history. Little is known about which characteristics people value in potential mates. Five predictions were made about sex differences in human mate preferences based on evolutionary conceptions of parental investment, sexual selection, human reproductive capacity, and sexual asymmetries regarding certainty of paternity versus maternity. The predictions centered on how each sex valued earning capacity, ambition— industriousness, youth, physical attractiveness, and chastity. Predictions were tested in data from 37 samples drawn from 33 countries located on six continents and five islands (total N = 10,047). For 27 countries, demographic data on actual age at marriage provided a validity check on questionnaire data. Females were found to value cues to resource acquisition in potential mates more highly than males. Characteristics signaling reproductive capacity were valued more by males than by females. These sex differences may reflect different evolutionary selection pressures on human males and females; they provide powerful cross-cultural evidence of current sex differences in reproductive strategies. Discussion focuses on proximate mechanisms underlying mate preferences, consequences for human intrasexual competition, and the limitations of this study. [3]

[4] Opinion Paper: “So what if ChatGPT wrote it?” Multidisciplinary perspectives on opportunities, challenges and implications of generative conversational AI for research, practice and policy — International Journal of Information Management, 2023-03-11, doi:10.1016/j.ijinfomgt.2023.102642

Transformative artificially intelligent tools, such as ChatGPT, designed to generate sophisticated text indistinguishable from that produced by a human, are applicable across a wide range of contexts. The technology presents opportunities as well as, often ethical and legal, challenges, and has the potential for both positive and negative impacts for organisations, society, and individuals. Offering multi-disciplinary insight into some of these, this article brings together 43 contributions from experts in fields such as computer science, marketing, information systems, education, policy, hospitality and tourism, management, publishing, and nursing. The contributors acknowledge ChatGPT’s capabilities to enhance productivity and suggest that it is likely to offer significant gains in the banking, hospitality and tourism, and information technology industries, and enhance business activities, such as management and marketing. Nevertheless, they also consider its limitations, disruptions to practices, threats to privacy and security, and consequences of biases, misuse, and misinformation. However, opinion is split on whether ChatGPT’s use should be restricted or legislated. Drawing on these contributions, the article identifies questions requiring further research across three thematic areas: knowledge, transparency, and ethics; digital transformation of organisations and societies; and teaching, learning, and scholarly research. The avenues for further research include: identifying skills, resources, and capabilities needed to handle generative AI; examining biases of generative AI attributable to training datasets and processes; exploring business and societal contexts best suited for generative AI implementation; determining optimal combinations of human and generative AI for various tasks; identifying ways to assess accuracy of text produced by generative AI; and uncovering the ethical and legal issues in using generative AI across different contexts. [4]